Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Oncogene|December 9, 2022
SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarkerWenjun Wu, Pin Lu, Priyal Patel, et al.
Clinical Genitourinary Cancer|October 26, 2019
Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell CarcinomaReza Nejati, Shuanzeng Wei, Robert G Uzzo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphomaZhihui Song, Wei Wei, Wenming Xiao, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2022
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinomaNils Kroeger, Cédric Lebacle, Justine Hein, et al.
American Journal of Clinical Pathology|May 15, 2023
Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP WorkshopJames R Cook, Catalina Amador, Magdalena Czader, et al.
Leukemia|November 12, 2025
The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphomaWei Wei, Zhihui Song, Yajun Wang, et al.
American Journal of Clinical Pathology|April 21, 2023
Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP WorkshopJohn R Goodlad, Wenbin Xiao, Catalina Amador, et al.
Cold Spring Harbor Molecular Case Studies|September 20, 2023
Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL)Patricia M Kim, Reza Nejati, Pin Lu, et al.
American Journal of Clinical Pathology|April 21, 2023
Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP WorkshopReza Nejati, Catalina Amador, Magdalena Czader, et al.
Leukemia|July 10, 2025
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implicationsJessica Atkins, Anna-Mariya Kukuyan, Monika Toma, et al.
Pageof 6